SEC Info - Allscripts Healthcare Solutions, Inc. - ‘10-Q’ for 6/30/13

SEC Info℠

Home

Help

Please Sign In

Allscripts Healthcare Solutions, Inc. – ‘10-Q’ for 6/30/13 – ‘XML.R7’

On: Friday, 8/9/13, at 4:02pm ET · For: 6/30/13 · Accession #: 1193125-13-329137 · File #: 1-35547

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/13  Allscripts Healthcare Soluti… Inc 10-Q        6/30/13  133:11M                                    Donnelley … Solutions/FA

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    831K 
 2: EX-10.16    Material Contract                                   HTML     54K 
 3: EX-10.17    Material Contract                                   HTML     40K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     40K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     40K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     35K 
130: R1          Document and Entity Information                     HTML     56K  
79: R2          Consolidated Balance Sheets                         HTML    145K 
74: R3          Consolidated Balance Sheets (Parenthetical)         HTML     61K 
19: R4          Consolidated Statements of Operations               HTML     97K 
77: R5          Consolidated Statements of Comprehensive Income     HTML     69K 
                (Loss)                                                           
50: R6          Consolidated Statements of Cash Flows               HTML    135K 
107: R7          Consolidated Statements of Cash Flows               HTML     35K  
                (Parenthetical)                                                  
53: R8          Summary of Significant Accounting Policies          HTML     53K 
58: R9          Business Combinations                               HTML     77K 
20: R10         Fair Value Measurements                             HTML     71K 
55: R11         Stockholders' Equity                                HTML     87K 
106: R12         Earnings Per Share                                  HTML     68K  
100: R13         Goodwill and Intangible Assets                      HTML     85K  
75: R14         Debt                                                HTML    100K 
124: R15         Income Taxes                                        HTML     48K  
104: R16         Derivative Financial Instruments                    HTML     65K  
16: R17         Contingencies                                       HTML     55K 
24: R18         Business Segments                                   HTML     75K 
123: R19         North American Site Consolidation Plan              HTML     39K  
128: R20         Summary of Significant Accounting Policies          HTML     70K  
                (Policies)                                                       
132: R21         Summary of Significant Accounting Policies          HTML     40K  
                (Tables)                                                         
126: R22         Business Combinations (Tables)                      HTML     71K  
90: R23         Fair Value Measurements (Tables)                    HTML     61K 
21: R24         Stockholders' Equity (Tables)                       HTML     75K 
49: R25         Earnings Per Share (Tables)                         HTML     69K 
33: R26         Goodwill and Intangible Assets (Tables)             HTML     82K 
32: R27         Debt (Tables)                                       HTML     81K 
60: R28         Income Taxes (Tables)                               HTML     42K 
89: R29         Derivative Financial Instruments (Tables)           HTML     48K 
102: R30         Business Segments (Tables)                          HTML     68K  
41: R31         Amounts Reclassified (Detail)                       HTML     36K 
61: R32         Business Combinations - Additional Information      HTML    109K 
                (Detail)                                                         
115: R33         Fair Value of Consideration Transferred for         HTML     47K  
                Acquisition (Detail)                                             
36: R34         Fair Value of Consideration Transferred for         HTML     45K 
                Acquisition (Parenthetical) (Detail)                             
97: R35         Assets Acquired and Liabilities Assumed (Detail)    HTML     63K 
98: R36         Acquired Intangible Assets Amortization (Detail)    HTML     43K 
64: R37         Proforma Results (Detail)                           HTML     52K 
31: R38         Summary of Financial Assets and Liabilities         HTML     68K 
                Measured at Fair Value on Recurring Basis (Detail)               
94: R39         Fair Value Measurements - Additional Information    HTML     61K 
                (Detail)                                                         
39: R40         Weighted Average Input Assumptions (Detail)         HTML     47K 
59: R41         Stock-Based Compensation Expense (Detail)           HTML     58K 
103: R42         Stock-Based Awards Granted (Detail)                 HTML     50K  
46: R43         Stockholders' Equity - Additional Information       HTML     97K 
                (Detail)                                                         
91: R44         Calculations of Earnings Per Share (Detail)         HTML     64K 
73: R45         Anti-Dilutive Stock Options, Restricted Stock Unit  HTML     39K 
                Awards and Warrants Excluded from Computation of                 
                Diluted (Loss) Earnings Per Share (Detail)                       
35: R46         Goodwill and Intangible Assets (Detail)             HTML     52K 
111: R47         Goodwill and Intangible Assets - Additional         HTML     43K  
                Information (Detail)                                             
29: R48         Changes in Carrying Amount of Goodwill (Detail)     HTML     75K 
40: R49         Debt Outstanding (Detail)                           HTML     49K 
72: R50         Interest Expense (Detail)                           HTML     49K 
83: R51         Debt - Additional Information (Detail)              HTML    201K 
109: R52         Summary of Future Payments under Notes and Senior   HTML     65K  
                Secured Credit Facilities (Detail)                               
17: R53         Effective Tax Rates (Detail)                        HTML     44K 
93: R54         Income Taxes - Additional Information (Detail)      HTML     41K 
66: R55         Derivative Financial Instruments - Additional       HTML     88K 
                Information (Detail)                                             
23: R56         Activity Related to Interest Rate Swap Agreement    HTML     49K 
                (Detail)                                                         
30: R57         Contingencies - Additional Information (Detail)     HTML     47K 
78: R58         Revenues and Income from Operations Related to      HTML     50K 
                Segment Within Reconciliation to Consolidated                    
                Amounts (Detail)                                                 
118: R59         North American Site Consolidation Plan -            HTML     55K  
                Additional Information (Detail)                                  
70: XML         IDEA XML File -- Filing Summary                      XML    140K 
133: XML.R1      Document and Entity Information                      XML    143K  
57: XML.R2      Consolidated Balance Sheets                          XML    375K 
88: XML.R3      Consolidated Balance Sheets (Parenthetical)          XML    149K 
69: XML.R4      Consolidated Statements of Operations                XML    466K 
65: XML.R5      Consolidated Statements of Comprehensive Income      XML    212K 
                (Loss)                                                           
14: XML.R6      Consolidated Statements of Cash Flows                XML    396K 
81: XML.R7      Consolidated Statements of Cash Flows                XML     74K 
                (Parenthetical)                                                  
13: XML.R8      Summary of Significant Accounting Policies           XML     68K 
45: XML.R9      Business Combinations                                XML    100K 
63: XML.R10     Fair Value Measurements                              XML     91K 
54: XML.R11     Stockholders' Equity                                 XML    107K 
47: XML.R12     Earnings Per Share                                   XML     92K 
112: XML.R13     Goodwill and Intangible Assets                       XML    112K  
56: XML.R14     Debt                                                 XML    126K 
127: XML.R15     Income Taxes                                         XML     64K  
85: XML.R16     Derivative Financial Instruments                     XML     79K 
82: XML.R17     Contingencies                                        XML     64K 
87: XML.R18     Business Segments                                    XML     97K 
38: XML.R19     North American Site Consolidation Plan               XML     53K 
76: XML.R20     Summary of Significant Accounting Policies           XML    109K 
                (Policies)                                                       
101: XML.R21     Summary of Significant Accounting Policies           XML     56K  
                (Tables)                                                         
105: XML.R22     Business Combinations (Tables)                       XML    107K  
114: XML.R23     Fair Value Measurements (Tables)                     XML     83K  
62: XML.R24     Stockholders' Equity (Tables)                        XML    108K 
28: XML.R25     Earnings Per Share (Tables)                          XML     97K 
121: XML.R26     Goodwill and Intangible Assets (Tables)              XML    114K  
86: XML.R27     Debt (Tables)                                        XML    118K 
122: XML.R28     Income Taxes (Tables)                                XML     59K  
22: XML.R29     Derivative Financial Instruments (Tables)            XML     66K 
99: XML.R30     Business Segments (Tables)                           XML     91K 
96: XML.R31     Amounts Reclassified (Detail)                        XML     81K 
27: XML.R32     Business Combinations - Additional Information       XML    773K 
                (Detail)                                                         
125: XML.R33     Fair Value of Consideration Transferred for          XML    103K  
                Acquisition (Detail)                                             
25: XML.R34     Fair Value of Consideration Transferred for          XML    121K 
                Acquisition (Parenthetical) (Detail)                             
129: XML.R35     Assets Acquired and Liabilities Assumed (Detail)     XML    188K  
116: XML.R36     Acquired Intangible Assets Amortization (Detail)     XML    234K  
110: XML.R37     Proforma Results (Detail)                            XML    243K  
113: XML.R38     Summary of Financial Assets and Liabilities          XML    878K  
                Measured at Fair Value on Recurring Basis (Detail)               
68: XML.R39     Fair Value Measurements - Additional Information     XML    240K 
                (Detail)                                                         
51: XML.R40     Weighted Average Input Assumptions (Detail)          XML    101K 
131: XML.R41     Stock-Based Compensation Expense (Detail)            XML    286K  
95: XML.R42     Stock-Based Awards Granted (Detail)                  XML    270K 
120: XML.R43     Stockholders' Equity - Additional Information        XML    764K  
                (Detail)                                                         
26: XML.R44     Calculations of Earnings Per Share (Detail)          XML    219K 
84: XML.R45     Anti-Dilutive Stock Options, Restricted Stock Unit   XML     81K 
                Awards and Warrants Excluded from Computation of                 
                Diluted (Loss) Earnings Per Share (Detail)                       
48: XML.R46     Goodwill and Intangible Assets (Detail)              XML    214K 
80: XML.R47     Goodwill and Intangible Assets - Additional          XML    131K 
                Information (Detail)                                             
71: XML.R48     Changes in Carrying Amount of Goodwill (Detail)      XML   1.02M 
42: XML.R49     Debt Outstanding (Detail)                            XML    289K 
92: XML.R50     Interest Expense (Detail)                            XML    134K 
43: XML.R51     Debt - Additional Information (Detail)               XML   3.45M 
52: XML.R52     Summary of Future Payments under Notes and Senior    XML    493K 
                Secured Credit Facilities (Detail)                               
15: XML.R53     Effective Tax Rates (Detail)                         XML    113K 
108: XML.R54     Income Taxes - Additional Information (Detail)       XML     92K  
117: XML.R55     Derivative Financial Instruments - Additional        XML    900K  
                Information (Detail)                                             
34: XML.R56     Activity Related to Interest Rate Swap Agreement     XML    134K 
                (Detail)                                                         
37: XML.R57     Contingencies - Additional Information (Detail)      XML    132K 
18: XML.R58     Revenues and Income from Operations Related to       XML    530K 
                Segment Within Reconciliation to Consolidated                    
                Amounts (Detail)                                                 
119: XML.R59     North American Site Consolidation Plan -             XML    276K  
                Additional Information (Detail)                                  
67: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.03M 
 7: EX-101.INS  XBRL Instance -- mdrx-20130630                       XML   1.67M 
 9: EX-101.CAL  XBRL Calculations -- mdrx-20130630_cal               XML    226K 
10: EX-101.DEF  XBRL Definitions -- mdrx-20130630_def                XML    640K 
11: EX-101.LAB  XBRL Labels -- mdrx-20130630_lab                     XML   1.32M 
12: EX-101.PRE  XBRL Presentations -- mdrx-20130630_pre              XML    924K 
 8: EX-101.SCH  XBRL Schema -- mdrx-20130630                         XSD    198K 
44: ZIP         XBRL Zipped Folder -- 0001193125-13-329137-xbrl      Zip    172K

‘XML.R7’ — Consolidated Statements of Cash Flows (Parenthetical)

This Financial Report is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<ReportLongName> 108 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) </ReportLongName>

<ShowElementNames> false </ShowElementNames>

<HasEmbeddedReports> false </HasEmbeddedReports>

<IsAbstractGroupTitle> false </IsAbstractGroupTitle>

<hasSegments> false </hasSegments>

<hasScenarios> false </hasScenarios>

<MCU>

<PeriodType> instant </PeriodType>

</contextRef>

<UPS>

<UnitType> Standard </UnitType>

<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema>

</StandardMeasure>

</Measure>

</Measure>

</MultiplyMeasures>

</NumeratorMeasure>

</DenominatorMeasure>

</UnitProperty>

</UPS>

</MCU>

</Labels>

</Column>

<IsAbstractGroupTitle> false </IsAbstractGroupTitle>

<hasSegments> false </hasSegments>

<hasScenarios> false </hasScenarios>

<MCU>

<PeriodType> instant </PeriodType>

</contextRef>

<UPS>

<UnitType> Standard </UnitType>

<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema>

</StandardMeasure>

</Measure>

</Measure>

</MultiplyMeasures>

</NumeratorMeasure>

</DenominatorMeasure>

</UnitProperty>

</UPS>

</MCU>

</Labels>

</Column>

</Columns>

<Rows>

<IsAbstractGroupTitle> false </IsAbstractGroupTitle>

<IsReportTitle> false </IsReportTitle>

<IsCalendarTitle> false </IsCalendarTitle>

<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>

<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>

<IsBeginningBalance> false </IsBeginningBalance>

<IsEndingBalance> false </IsEndingBalance>

<IsReverseSign> false </IsReverseSign>

<Cells>

<IsNumeric> false </IsNumeric>

<IsRatio> false </IsRatio>

<DisplayZeroAsNone> false </DisplayZeroAsNone>

<IsIndependantCurrency> false </IsIndependantCurrency>

<ShowCurrencySymbol> false </ShowCurrencySymbol>

<DisplayDateInUSFormat> false </DisplayDateInUSFormat>

</Cell>

<IsNumeric> false </IsNumeric>

<IsRatio> false </IsRatio>

<DisplayZeroAsNone> false </DisplayZeroAsNone>

<IsIndependantCurrency> false </IsIndependantCurrency>

<ShowCurrencySymbol> false </ShowCurrencySymbol>

<DisplayDateInUSFormat> false </DisplayDateInUSFormat>

</Cell>

</Cells>

<IsAbstractGroupTitle> false </IsAbstractGroupTitle>

<hasScenarios> false </hasScenarios>

<MCU>

<PeriodType> instant </PeriodType>

<IsDefaultForEntity> false </IsDefaultForEntity>

<Name/>

<IsFromEntityGroup> false </IsFromEntityGroup>

<ValueName> Senior cash convertible notes [Member] </ValueName>

<ValueType> us-gaap_LongtermDebtTypeAxis </ValueType>

<Namespace> xbrldi </Namespace>

<Schema> http://xbrl.org/2006/xbrldi </Schema>

<Id> mdrx_SeniorConvertibleNotesMember </Id>

<dimensionId> us-gaap_LongtermDebtTypeAxis </dimensionId>

<type> explicitMember </type>

</DimensionInfo>

</anyType>

</Segments>

</contextRef>

<UPS>

<UnitType> Standard </UnitType>

<MeasureSchema> http://www.xbrl.org/2003/instance </MeasureSchema>

</StandardMeasure>

</Measure>

</Measure>

</MultiplyMeasures>

</NumeratorMeasure>

</DenominatorMeasure>

</UnitProperty>

</UPS>

</MCU>

</Labels>

</OriginalInstanceReportColumn>

<IsTotalLabel> false </IsTotalLabel>

<Label> Senior cash convertible notes [Member] </Label>

</Row>

<IsAbstractGroupTitle> false </IsAbstractGroupTitle>

<ElementName> us-gaap_DebtInstrumentInterestRateStatedPercentage </ElementName>

<PeriodType> instant </PeriodType>

<IsReportTitle> false </IsReportTitle>

<IsSegmentTitle> false </IsSegmentTitle>

<IsCalendarTitle> false </IsCalendarTitle>

<IsEquityPrevioslyReportedAsRow> false </IsEquityPrevioslyReportedAsRow>

<IsEquityAdjustmentRow> false </IsEquityAdjustmentRow>

<IsBeginningBalance> false </IsBeginningBalance>

<IsEndingBalance> false </IsEndingBalance>

<IsReverseSign> false </IsReverseSign>

<PreferredLabelRole> terseLabel </PreferredLabelRole>

<Cells>

<DisplayZeroAsNone> false </DisplayZeroAsNone>

<IsIndependantCurrency> false </IsIndependantCurrency>

<ShowCurrencySymbol> false </ShowCurrencySymbol>

<DisplayDateInUSFormat> false </DisplayDateInUSFormat>

</Cell>

<DisplayZeroAsNone> false </DisplayZeroAsNone>

<IsIndependantCurrency> false </IsIndependantCurrency>

<ShowCurrencySymbol> false </ShowCurrencySymbol>

<DisplayDateInUSFormat> false </DisplayDateInUSFormat>

</Cell>

</Cells>

<ElementDataType> num:percentItemType </ElementDataType>

<ElementDefenition> Contractual interest rate for funds borrowed, under the debt agreement. </ElementDefenition>

<ElementReferences> Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 </ElementReferences>

<IsTotalLabel> false </IsTotalLabel>

<Label> Debt instrument interest rate </Label>

</Row>

</Rows>

<IsEquityReport> false </IsEquityReport>

<ReportName> CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) (Senior cash convertible notes [Member]) </ReportName>

<MonetaryRoundingLevel> UnKnown </MonetaryRoundingLevel>

<SharesRoundingLevel> UnKnown </SharesRoundingLevel>

<PerShareRoundingLevel> UnKnown </PerShareRoundingLevel>

<ExchangeRateRoundingLevel> UnKnown </ExchangeRateRoundingLevel>

<IsEmbedReport> false </IsEmbedReport>

<IsMultiCurrency> false </IsMultiCurrency>

<ReportType> Sheet </ReportType>

<RoleURI> http://www.allscripts.com/taxonomy/role/StatementOfCashFlowsIndirectParenthetical </RoleURI>

</InstanceReport>

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/22  Veradigm Inc.                     10-K/A     12/31/21   12:4M                                     Donnelley … Solutions/FA
 2/25/22  Veradigm Inc.                     10-K       12/31/21  150:28M                                    Donnelley … Solutions/FA
 2/26/21  Veradigm Inc.                     10-K       12/31/20  165:35M                                    ActiveDisclosure/FA

↑Top

Filing Submission 0001193125-13-329137 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Allscripts Healthcare Solutions, Inc. – ‘10-Q’ for 6/30/13 – ‘XML.R7’

On: Friday, 8/9/13, at 4:02pm ET · For: 6/30/13 · Accession #: 1193125-13-329137 · File #: 1-35547

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘XML.R7’ — Consolidated Statements of Cash Flows (Parenthetical)

This Financial Report is an XBRL XML File.

3 Subsequent Filings that Reference this Filing

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents